Ident. | Authors (with country if any) | Title |
---|
000589 (2012) |
Desta Ayode [Éthiopie, États-Unis, Royaume-Uni] ; Colleen M. Mcbride ; Hendrik De Heer ; Emi Watanabe ; Tsega Gebreyesus ; Getnet Tadele ; Abebayehu Tora ; Gail Davey | The Association of Beliefs About Heredity with Preventive and Interpersonal Behaviors in Communities Affected by Podoconiosis in Rural Ethiopia |
000593 (2012) |
Sabine Mand [Allemagne] ; Alexander Yaw Debrah [Ghana] ; Ute Klarmann [Allemagne] ; Linda Batsa [Ghana] ; Yeboah Marfo-Debrekyei [Ghana] ; Alexander Kwarteng [Ghana] ; Sabine Specht [Allemagne] ; Aurea Belda-Domene [Allemagne] ; Rolf Fimmers [Allemagne] ; Mark Taylor [Royaume-Uni] ; Ohene Adjei ; Achim Hoerauf [Allemagne] | Doxycycline Improves Filarial Lymphedema Independent of Active Filarial Infection: A Randomized Controlled Trial |
000955 (2008) |
Tayebeh Rezaie [États-Unis] ; Rose Ghoroghchian [États-Unis] ; Rachel Bell [Royaume-Uni] ; Glen Brice [Royaume-Uni] ; Ali Hasan [Royaume-Uni] ; Kevin Burnand [Royaume-Uni] ; Steve Vernon [Royaume-Uni] ; Sahar Mansour [Royaume-Uni] ; Peter Mortimer (dermatologue) [Royaume-Uni] ; Steve Jeffery [Royaume-Uni] ; Anne Child [Royaume-Uni] ; Mansoor Sarfarazi [États-Unis] | Primary non-syndromic lymphoedema (Meige disease) is not caused by mutations in FOXC2 |
000956 (2008) |
Fasil Tekola [Royaume-Uni] ; Zewdu Ayele [Éthiopie] ; DEREJE HAILE MARIAM [Éthiopie] ; Claire Fuller [Royaume-Uni] ; Gail Davey [Éthiopie] | Development and testing of a de novo clinical staging system for podoconiosis (endemic non-filarial elephantiasis) |
000A35 (2007) |
Clare Shaw [Royaume-Uni] ; Peter Mortimer (dermatologue) [Royaume-Uni] ; Patricia A. Judd [Royaume-Uni] | Randomized controlled trial comparing a low-fat diet with a weight-reduction diet in breast cancer-related lymphedema |
000A38 (2007) |
Anand D. Purushotham [Royaume-Uni] ; Thomas M. Bennett Britton [Royaume-Uni] ; Manfred B. Klevesath [Royaume-Uni] ; Patrick Chou [Royaume-Uni] ; Olorunsola F. Agbaje [Royaume-Uni] ; Stephen W. Duffy [Royaume-Uni] | Lymph node status and breast cancer-related lymphedema |
000A39 (2007) |
Clare Shaw [Royaume-Uni] ; Peter Mortimer (dermatologue) [Royaume-Uni] ; Patricia A. Judd [Royaume-Uni] | A randomized controlled trial of weight reduction as a treatment for breast cancer-related lymphedema |
000B21 (2006) |
J. Welsh [Royaume-Uni] ; M. Todd [Royaume-Uni] | Incidence and characteristics of lymphedema in Turner's syndrome |
000B23 (2006) |
Tess Mcpherson [États-Unis, Guyana, Royaume-Uni] ; Michael P. Fay ; Shanti Singh ; Rebecca Penzer ; Rod Hay | Health workers' agreement in clinical description of filarial lymphedema |
000B24 (2006) |
Anthony W. B. Stanton [Royaume-Uni] ; Stephanie Modi [Royaume-Uni] ; Russell H. Mellor [Royaume-Uni] ; A. Mike Peters [Royaume-Uni] ; William E. Svensson [Royaume-Uni] ; J. Rodney Levick [Royaume-Uni] ; Peter S. Mortimer [Royaume-Uni] | A quantitative lymphoscintigraphic evaluation of lymphatic function in the swollen hands of women with lymphoedema following breast cancer treatment |
000B76 (2005) |
Carolyn Sholto-Douglas-Vernon [Royaume-Uni] ; Rachel Bell [Royaume-Uni] ; Glen Brice [Royaume-Uni] ; Sahar Mansour [Royaume-Uni] ; Mansoor Sarfarazi [États-Unis] ; Anne H. Child [Royaume-Uni] ; Alberto Smith [Royaume-Uni] ; Russell Mellor [Royaume-Uni] ; Kevin Burnand [Royaume-Uni] ; Peter Mortimer (dermatologue) [Royaume-Uni] ; Steve Jeffery [Royaume-Uni] | Lymphoedema-distichiasis and FOXC2 : unreported mutations, de novo mutation estimate, families without coding mutations |
000C47 (2004) |
A. A. Okeke [Royaume-Uni] ; D. O. Bates [Royaume-Uni] ; D. A. Gillatt [Royaume-Uni] | Lymphoedema in urological cancer |
000C86 (2003) |
C. J. Moffatt ; P. J. Franks ; D. C. Doherty ; A. F. Williams ; C. Badger ; E. Jeffs ; N. Bosanquet [Royaume-Uni] ; Peter Mortimer (dermatologue) [Royaume-Uni] | Lymphoedema: an underestimated health problem |
000C99 (2003) |
A. Mallick [Royaume-Uni] ; A. R. Bodenham [Royaume-Uni] | Disorders of the lymph circulation: their relevance to anaesthesia and intensive care |
000D15 (2003) |
S. J. Pain [Royaume-Uni] ; S. L. Vowler [Royaume-Uni] ; A. D. Purushotham [Royaume-Uni] | Is physical function a more appropriate measure than volume excess in the assessment of breast cancer-related lymphoedema (BCRL)? |
000D16 (2003) |
R. S. Rampaul [Royaume-Uni] ; K. Mullinger [Royaume-Uni] ; R. D. Macmillan [Royaume-Uni] ; J. Cid [Royaume-Uni] ; S. Holmes [Royaume-Uni] ; D. A. L. Morgan [Royaume-Uni] ; R. W. Blamey [Royaume-Uni] | Incidence of clinically significant lymphoedema as a complication following surgery for primary operable breast cancer |
000D17 (2003) |
Martin Frühwirth [Autriche, États-Unis, Royaume-Uni, Norvège] ; Andreas R. Janecke ; Thomas Müller ; Victoria E. H. Carlton ; Florian Kronenberg ; Felix Offner ; A. S. Knisely ; Silvana Geleff ; Eyun J. Song ; Burkhard Simma ; Alfred Königsrainer ; Raimund Margreiter ; C. B. Van Der Hagen ; Kristin Eiklid ; Ystein Aagenaes ; Laura Bull ; Helmut Ellemunter | Evidence for genetic heterogeneity in lymphedema-cholestasis syndrome |
000D18 (2003) |
Alok Tiwari [Royaume-Uni] ; Koon-Sung Cheng [Royaume-Uni] ; Matthew Button [Royaume-Uni] ; Fiona Myint [Royaume-Uni] ; George Hamilton [Royaume-Uni] | Differential diagnosis, investigation, and current treatment of lower limb lymphedema |
000D60 (2002) |
A. P. Souka [Royaume-Uni] ; E. Krampl [Royaume-Uni] ; L. Geerts [Royaume-Uni] ; K. H. Nicolaides [Royaume-Uni] | Congenital lymphedema presenting with increased nuchal translucency at 13 weeks of gestation |
000D74 (2002) |
Simon J. Pain [Royaume-Uni] ; R. Steven Nicholas [Royaume-Uni] ; Robert W. Barber [Royaume-Uni] ; James R. Ballinger [Royaume-Uni] ; Arnie D. Purushotham [Royaume-Uni] ; Peter S. Mortimer [Royaume-Uni] ; A. Michael Peters [Royaume-Uni] | Quantification of lymphatic function for investigation of lymphedema: Depot clearance and rate of appearance of soluble macromolecules in blood |
000D75 (2002) |
S. M. R. Kabir [Royaume-Uni] ; A. Raurell [Royaume-Uni] ; V. Ramakrishnan [Royaume-Uni] | Lymphoedema of the eyelids |